If you’re looking for industry talent trends in Europe, you can’t do much better than the European Life Sciences Networks’ JobsInLifeSciences.com site, which not only lists the job openings and locations, but links you to more than 200 organizations, organized by country.
Italy’s Recordati, a leading maker of medicinal products, is expanding its presence in Turkey with a new manufacturing plant in the Cerkezkoy Organized Industrial Zone in Tekirdag province in northwestern Turkey. The US$50-million investment project, aided by the Investment Support and Promotion Agency of Turkey (ISPAT), will significantly increase Recordati’s manufacturing capacity to meet the needs of both the domestic and regional markets. The plant will supply drugs for various therapeutic uses, in particular cardiovascular and urogenital diseases, and will create 130 new jobs.
In February, executives of Vancouver, B.C.-based dental suture and surgical supply firm Surgical Specialties announced the company will invest $11 million in its new manufacturing facility in Tijuana, Mexico. “We analyzed several destinations and found that Tijuana has the strongest knowledge base and experience in medical device manufacturing, costs reduction, and immediate connectivity with major markets by land and sea,” said Victor Diaz, president and COO.
Surgical Specialties, which employs 1,400 people worldwide, will establish 173,000-sq.-ft. facility located in CPA´s Tijuana business center, an industrial development 10 minutes away from Tijuana-San Diego commercial crossing. Initially the new plant will produce blades and sutures for surgical use, and is projected to employ 900 people over the next two years. The set-up process was completed in two and a half months, supported by Tijuana EDC.
Tenet Healthcare subsidiary Conifer Health Solutions will open its new corporate headquarters in Frisco, Texas, this week, adding up to 500 jobs to its current payroll of 700. The 200-sq.-ft. building was developed by Duke Realty. The company in November received a Blueprint Award from the Dallas Regional Chamber for its positive impact on the area economy.
The Milken Institute has joined with the Sumner M. Redstone Charitable Foundation and the Milken Family Foundation to make a combined gift of $80 million to The George Washington University — a record for the school — to help address the world's public health challenges, focusing on prevention of disease and promotion of wellness. GWU’s School of Public Health and Health Services will be renamed as the Milken Institute School of Public Health, and the school will also establish the Sumner M. Redstone Global Center for Prevention and Wellness.
"Washington, D.C., is the center of global public health policy, and GW boasts the leading academic public health institution in Washington," said Institute President Paul Irving. "We are delighted to support the talented public health scholars and students of GW and look forward to helping the university extend its reach and impact even further."
An architectural rendering shows the new Milken Institute School of Public Health at the George Washington University, as seen from Washington Circle.
Image courtesy of the George Washington University
The 11th euRobotics Technology Transfer Award was recently presented during the European Robotics Forum 2014 in Rovereto, Italy. This year, the winner was “Float” (Free Levitation for Overground Active Training), an overhead body-weight support system based on a cable-driven robotic setup, which primarily helps patients learn to walk.
Float (pictured) is the result of a joint collaboration between Lutz Medical Engineering (MSc. Peter Lutz), ETH Zurich (Dr. Heike Vallery), and Spinal Cord Injury Center Balgrist (Dr. Marc Bolliger). Float is CE-certified and already on the market. Dr. Heike Vallery, the newly appointed Assistant Professor at TU Delft, who presented the winning application, said: “Float is currently the only commercially available 3D body weight support system, and it meets a high market demand.”
The euRobotics Technology Transfer Award is presented each year in recognition of outstanding innovations in the field of robotics and automation, in order to promote excellence in applied research, and technology transfer between research and industry. The award is supported by EUnited Robotics, the European Robotics Association, and is financially sponsored by the following industrial members: ABB, KUKA Roboter, COMAU, GÜDEL, and SCHUNK.
Bayer plans to spend nearly $700 million to expand production capacity in Germany, where it plans to manufacture its two experimental hemophilia A drugs. “This investment will be one of the largest in the history of Bayer HealthCare and reflects our strong commitment in the field of hemophilia A,” said Dr. Olivier Brandicourt, CEO of Bayer HealthCare. As part of this investment Bayer HealthCare will create about 500 new jobs at its sites in Leverkusen and Wuppertal by the year 2020.
A jobs impact report released in January said a proposal to reform Georgia's medical malpractice system would save businesses $25 billion in the first 10 years. The study, conducted with BioScience Valuation by economics professor Joanna Shepherd-Bailey, Ph.D., of the Emory University School of Law, examined the effect of Georgia Senate Bill 141, which would have ended medical malpractice litigation in the state and create a patients compensation system (PCS) instead. However, the bill was a “crossover casualty” early this month as the Georgia Assembly’s session neared its end.
The Economist describes an intriguing new partnership between Pfizer and Siemens.
The University of California, Irvine in late February announced the creation of the UC Irvine Institute for Innovation. The Institute, funded with an initial $5 million, will expand upon the success of the Beall Center for Innovation & Entrepreneurship at The Paul Merage School of Business, and will incorporate UC Irvine's Office of Technology Alliances, which handles the patenting and licensing of the campus's intellectual property, and the functions of corporate relations and industry-sponsored research.
“Allergan and UC Irvine share a commitment to scientific excellence and life-improving discoveries,” said David E.I. Pyott, chairman of the board and CEO of Allergan Inc. “As our neighbor, UC Irvine has been a source for providing robust research and a talented workforce. We welcome the formation of UC Irvine's Institute for Innovation, which demonstrates the university's continuing dedication to delivering ideas that improve the economic, individual and cultural health of the region and the world.”
The infographic below details UCI’s innovation impact:
RSS FEED
